Baird Medical Investment Holdings Limited
BDMD · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $97 | $165 | $83 | $55 |
| - Cash | $2 | $3 | $2 | $0 |
| + Debt | $23 | $21 | $16 | $0 |
| Enterprise Value | $117 | $183 | $97 | $55 |
| Revenue | $8 | $24 | $13 | $20 |
| % Growth | -66.7% | 81.9% | -34% | – |
| Gross Profit | $7 | $21 | $11 | $18 |
| % Margin | 82.1% | 88.5% | 87.5% | 89% |
| EBITDA | -$10 | $11 | $6 | $9 |
| % Margin | -121.3% | 45.1% | 43.3% | 47.6% |
| Net Income | -$11 | $8 | $4 | $8 |
| % Margin | -141.9% | 34% | 33% | 41.3% |
| EPS Diluted | -0.43 | 0.38 | -0.318 | 0.38 |
| % Growth | -213.2% | 219.5% | -183.7% | – |
| Operating Cash Flow | -$3 | -$2 | -$4 | -$2 |
| Capital Expenditures | -$0 | -$2 | -$0 | -$1 |
| Free Cash Flow | -$3 | -$5 | -$4 | -$3 |